using biomarkers to identify bladder cancer patients for neoadjuvant therapy
Published 6 years ago • 63 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
1:44
positive biomarkers to select patients for bladder preservation in bladder cancer
-
1:06:18
biomarker-guided neoadjuvant therapy for bladder cancer
-
1:08
the role of molecular biomarkers in determining patient response to bladder cancer treatment
-
1:25
overcoming challenges in localized bladder cancer management via biomarkers
-
1:29
biomarker identification in nsclc treated with neoadjuvant chemo-io
-
1:24
optimizing neoadjuvant therapy in nsclc with biomarker research
-
6:49
the role of biomarkers in bladder cancer
-
1:49
immunotherapy and beyond for lung cancer prevention
-
2:43
genomic insights and biomarkers for treatment selection in bladder cancer
-
0:49
the need for biomarkers to aid in treatment decision making for upper tract urothelial carcinoma
-
0:57
biomarkers for muscle-invasive bladder cancer in the ambassador trial
-
2:59
predictive biomarkers of neoadjuvant chemosensitivity in muscle invasive bladder cancer | oncotarget
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
31:06
bladder cancer | 2022 oneoncology conference
-
8:00
neoadjuvant and adjuvant therapy in bladder cancer
-
6:08
question and answer about neoadjuvant and adjuvant chemotherapy for bladder cancer
-
1:07
exploring the role of biomarkers in patient selection for immunotherapy in bladder cancer
-
33:17
evaluating biomarkers for response to neoadjuvant immune checkpoint blockade..